Viewing StudyNCT03034967



Ignite Creation Date: 2024-05-06 @ 9:37 AM
Last Modification Date: 2024-10-26 @ 12:17 PM
Study NCT ID: NCT03034967
Status: COMPLETED
Last Update Posted: 2020-10-28
First Post: 2017-01-25

Brief Title: Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease COPD
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-04-25
Start Date Type: ACTUAL
Primary Completion Date: 2018-10-05
Primary Completion Date Type: ACTUAL
Completion Date: 2018-10-05
Completion Date Type: ACTUAL
First Submit Date: 2017-01-25
First Submit QC Date: January 25 2017
Study First Post Date: 2017-01-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2019-11-29
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-10-06
Last Update Post Date: 2020-10-28
Last Update Post Date Type: ACTUAL